JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Smoldering multiple myeloma: Integrating biology and risk into management

  • 0Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Seminars in Hematology +

|

November 27, 2024

|

November 27, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Smoldering multiple myeloma (SMM) is a precursor to symptomatic multiple myeloma (MM). Current risk models focus on disease volume, but understanding SMM genetics and the immune microenvironment is key to predicting progression and refining treatment strategies.

Area Of Science

  • Hematology
  • Oncology
  • Immunology

Background

  • Smoldering multiple myeloma (SMM) is a premalignant condition preceding symptomatic multiple myeloma (MM).
  • The progression of SMM to MM is influenced by the genetics of the premalignant clone and the immune microenvironment.
  • Existing clinical risk models for SMM progression primarily rely on disease volume, not underlying biological factors.

Purpose Of The Study

  • To review the history and biology of SMM.
  • To discuss the utility of current risk stratification models for SMM.
  • To examine emerging strategies challenging the standard management of SMM.

Main Methods

  • Literature review of SMM history, genetics, and immunology.
  • Analysis of existing clinical risk models for SMM progression.
  • Examination of recent research on early intervention in SMM.

Main Results

  • SMM progression to MM is multifactorial, involving genetic and immune components.
  • Current risk models have limitations in predicting progression due to their focus on disease volume.
  • Research is exploring biological markers to improve risk stratification and identify patients who may benefit from early intervention.

Conclusions

  • Accurate diagnosis of SMM is crucial to avoid overtreatment or undertreatment.
  • Understanding the biology of SMM is essential for developing more precise risk prediction tools.
  • Further research is needed to determine the optimal management strategy for SMM, potentially including early intervention for high-risk subgroups.

Keywords: